Voloridge Investment Management
CORT icon

Voloridge Investment Management’s Corcept Therapeutics CORT Stock Holding History

Voloridge Investment Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-181,571
Closed -$20.7M – 1194
2025
Q1 		$20.7M Sell
181,571
-290,052
-62% -$17.7M 0.08% 345
2024
Q4 		$23.8M Sell
471,623
-150,548
-24% -$7.89M 0.08% 304
2024
Q3 		$28.8M Sell
622,171
-147,243
-19% -$5.23M 0.1% 289
2024
Q2 		$25M Sell
769,414
-263,811
-26% -$7.23M 0.09% 300
2024
Q1 		$26M Buy
1,033,225
+485,928
+89% +$11.5M 0.1% 267
2023
Q4 		$17.8M Buy
547,297
+113,273
+26% +$3.11M 0.07% 351
2023
Q3 		$11.8M Buy
434,024
+398,787
+1,132% +$11.5M 0.06% 418
2023
Q2 		$784K Sell
35,237
-29,143
-45% -$671K ﹤0.01% 1162
2023
Q1 		$1.39M Sell
64,380
-1,951
-3% -$42.8K 0.01% 1061
2022
Q4 		$1.35M Sell
66,331
-175,642
-73% -$4.4M 0.01% 1066
2022
Q3 		$6.2M Sell
241,973
-70,870
-23% -$1.9M 0.03% 578
2022
Q2 		$7.44M Sell
312,843
-73,406
-19% -$1.6M 0.04% 544
2022
Q1 		$8.7M Buy
386,249
+318,425
+469% +$6.77M 0.05% 450
2021
Q4 		$1.34M Buy
+67,824
New +$1.38M 0.01% 1186
2021
Q2 		– Sell
-64,270
Closed -$1.53M – 1626
2021
Q1 		$1.53M Sell
64,270
-169,135
-72% -$4.52M 0.01% 903
2020
Q4 		$6.11M Sell
233,405
-119,498
-34% -$2.52M 0.05% 402
2020
Q3 		$6.14M Buy
352,903
+211,385
+149% +$3.37M 0.05% 389
2020
Q2 		$2.38M Buy
141,518
+17,197
+14% +$242K 0.03% 559
2020
Q1 		$1.48M Sell
124,321
-12,903
-9% -$160K 0.04% 425
2019
Q4 		$1.66M Buy
137,224
+101,284
+282% +$1.41M 0.03% 531
2019
Q3 		$508K Buy
+35,940
New +$442K 0.01% 805

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Voloridge Investment Management's CORT Position: Q2 2025 in Review

Voloridge Investment Management sold out of Corcept Therapeutics (CORT) in Q2 2025, closing a stake of 181,571 shares — an estimated $20.7M sold.

Voloridge Investment Management first reported a position in CORT in Q3 2019 and held it in 21 quarters. The position peaked at $28.8M in Q3 2024. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2025.

  • Voloridge Investment Management reported no remaining Corcept Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 181,571 Corcept Therapeutics shares in Q2 2025, an estimated $20.7M.
  • Voloridge Investment Management first reported a position in Corcept Therapeutics in Q3 2019 and held it in 21 quarters.
  • Voloridge Investment Management's Corcept Therapeutics position peaked at $28.8M in Q3 2024.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.